GAD1

Nitazoxanide : Nitazoxanide and COVID-19: A review

Adavosertib : Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial